Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,297,045
+$31,946,756 QoQ
Shares Held
4,221,836
+11615.0% QoQ
Ownership
5.03%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. REPL ranks #23 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,327,000 | $290,424,120 | |
| 2 | MANE |
Veradermics, Inc
|
4,168,970 | $263,270,455 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
1,153,496 | $143,783,276 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
3,518,471 | $141,548,088 | |
| 5 | LEGN |
Legend Biotech Corp
|
7,581,029 | $137,140,814 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $122,989,938 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
3,818,600 | $116,085,440 | |
| 8 | IMTX |
Immatics N.V.
|
11,190,129 | $110,110,869 |
All Filings in REPL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,297,045 | 4,221,836 | Shares | Sole | 2026-05-12 | |
| 2026-03-31 | $32,297,045 | 4,221,836 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $350,289 | 36,038 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||